Search research articles
Contact Us
Filters
Showing results (1-10 of 479) with videos related to
Page
of 48
Sort By:
Clinical Liver Disease
|
July 2, 2024
Liver biopsy: Archaic but resilient and many roads lead to Rome
K Rajender Reddy
Gastroenterology & Hepatology
|
March 15, 2017
Benign Lesions of the Liver
K Rajender Reddy
Gastroenterology Clinics of North America
|
May 12, 2020
Infections of the Liver and Biliary System
K Rajender Reddy
Gastroenterology & Hepatology
|
May 26, 2021
Liver Transplantation During the COVID-19 Pandemic
K Rajender Reddy
The American Journal of Gastroenterology
|
June 8, 2004
Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated
K Rajender Reddy
Clinical Liver Disease
|
June 4, 2020
SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections
K Rajender Reddy
Gastroenterology & Hepatology
|
April 28, 2016
Supplements and Hepatotoxicity
K Rajender Reddy
Seminars in Liver Disease
|
September 4, 2004
Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD)
K Rajender Reddy
Gastroenterology Clinics of North America
|
November 25, 2015
Hepatitis C: Unfolding the Challenges
K Rajender Reddy
Gastro Hep Advances
|
August 12, 2024
Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain
Madhumita Premkumar, K Rajender Reddy
Page
of 48
Search research articles
Search
Showing results (1-10 of 479) with videos related to
Sort By:
Page
of 48
Clinical Liver Disease
|
July 2, 2024
Liver biopsy: Archaic but resilient and many roads lead to Rome
K Rajender Reddy
Gastroenterology & Hepatology
|
March 15, 2017
Benign Lesions of the Liver
K Rajender Reddy
Gastroenterology Clinics of North America
|
May 12, 2020
Infections of the Liver and Biliary System
K Rajender Reddy
Gastroenterology & Hepatology
|
May 26, 2021
Liver Transplantation During the COVID-19 Pandemic
K Rajender Reddy
The American Journal of Gastroenterology
|
June 8, 2004
Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated
K Rajender Reddy
Clinical Liver Disease
|
June 4, 2020
SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections
K Rajender Reddy
Gastroenterology & Hepatology
|
April 28, 2016
Supplements and Hepatotoxicity
K Rajender Reddy
Seminars in Liver Disease
|
September 4, 2004
Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD)
K Rajender Reddy
Gastroenterology Clinics of North America
|
November 25, 2015
Hepatitis C: Unfolding the Challenges
K Rajender Reddy
Gastro Hep Advances
|
August 12, 2024
Treatment of Hepatorenal Syndrome-Acute Kidney Injury: Advances Made but Challenges Remain
Madhumita Premkumar, K Rajender Reddy
Page
of 48